We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Structured Anti-Bacterial Phage Hydrogel Heals Itself

By HospiMedica International staff writers
Posted on 06 Aug 2019
A new study describes how an anti-bacterial gel with self-organizing bundles of phage nanofilaments can be readily modified to target specific cells, including tumors.

Developed by researchers at McMaster University (Hamilton, ON, Canada), the novel gel is composed of self-organized M13 bacteriophage bundles, each made up of hundreds of cross-linked nanofilaments, which are capable of adsorbing water at up to 16 times their weight. More...
The hierarchical M13 hydrogels exhibit several advanced properties at room temperature, including self-healing under appropriate biological conditions, autofluorescence in three channels, biodegradation, non-destructive imaging capability and bioactivity toward host bacteria.

The bacteriophages assemble themselves spontaneously into liquid crystals; with the help of a chemical binder, they readily form a gelatin-like substance that can heal itself when cut. The cross-linked, self-organized hydrogel structures can thus serve as building blocks for bottom-up synthesis. Yellow in color, and with a consistency that resembles jelly, a single milliliter of the antibacterial hydrogel contains about 300 trillion phages. The study describing how the hydrogel is made was published on July 24, 2019, in ACS Chemistry of Materials.

“The DNA of phages can readily be modified to target specific cells, including cancer cells. Through a Nobel Prize-winning technology called phage display, it's even possible to find phages that target plastics or environmental pollutants,” said senior author Zeinab Hosseini-Doust, PhD, of the department of chemical engineering. “Being able to shape phages into solid form opens new vistas of possibility, just as their utility in fighting diseases is being realized, and holds promise for numerous beneficial applications in medicine and environmental protection.”

Bacteriophages are essentially bionanoparticles with a protein coat, the composition of which can be controlled with atomic precision via genetic engineering. They recognize their host via proteins that bind to structures on the surface of the bacteria. Phage proteins are also very stable; some of them require heating at temperatures above 90°C to destroy their 3D structure. Both properties provide durability in harsh environmental conditions, and allow bacteriophages to wait for the next opportunity to infect new host bacteria.

Related Links:
McMaster University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.